Hello Hitesh Bhai,
Found this article about bio similars and how Indian pharma companies lag behind in this field. It also talks about the shift of revenues from generics to bio similars.
https://uk.finance.yahoo.com/news/india-risks-missing-boat-biosimilars-210508796.html
Your comment would be highly appreciated.
Thanks and regards,
Nikhil